Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Digital Health, Diagnostic Focus Included In FDA Commissioner's 2018 Strategy

Jan 12 2018

• By Ferdous Al-Faruque

FDASignBldg21Entrance_1200x675

Related Content

US FDA Implements 'Firm-Based' Regulatory Approach To DTC Genetic Health Risk Tests

Nov 07 2017

A New York Minute: US FDA Leverages State's Health Department To Expedite NGS Reviews

Nov 15 2017

'Excellence' In Health-Software Design: US FDA Taps Nine Firms To Figure Out What That Means

Sep 26 2017

US FDA's New Game Plan For Digital Health

Jun 16 2017

Medtech's Unfinished Business For Congress In 2018: What's Ahead

Jan 11 2018

2018 An Inflection Point For mHealth After An Active Year

Jan 08 2018

Additional Topics

United States Digital Health Regulation FDA Medical Device In Vitro Diagnostics

More from Digital Technologies

More from Medtech Insight

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.